Back to Search
Start Over
Transcriptomic and phenotypic profiling in developing zebrafish exposed to thyroid hormone receptor agonists.
- Source :
-
Reproductive toxicology (Elmsford, N.Y.) [Reprod Toxicol] 2018 Apr; Vol. 77, pp. 80-93. Date of Electronic Publication: 2018 Feb 16. - Publication Year :
- 2018
-
Abstract
- There continues to be a need to develop in vivo high-throughput screening (HTS) and computational methods to screen chemicals for interaction with the estrogen, androgen, and thyroid pathways and as complements to in vitro HTS assays. This study explored the utility of an embryonic zebrafish HTS approach to identify and classify endocrine bioactivity using phenotypically-anchored transcriptome profiling. Transcriptome analysis was conducted on zebrafish embryos exposed to 25 estrogen-, androgen-, or thyroid-active chemicals at concentrations that elicited adverse malformations or mortality at 120 h post-fertilization in 80% of animals exposed. Analysis of the top 1000 significant differentially expressed transcripts and developmental toxicity profiles across all treatments identified a unique transcriptional and phenotypic signature for thyroid hormone receptor agonists. This unique signature has the potential to be used as a tiered in vivo HTS and may aid in identifying chemicals that interact with the thyroid hormone receptor.<br /> (Copyright © 2018 Elsevier Inc. All rights reserved.)
- Subjects :
- Androgens toxicity
Animals
Embryo, Nonmammalian drug effects
Estrogens toxicity
Gene Expression Profiling
Phenotype
Real-Time Polymerase Chain Reaction
Sequence Analysis, RNA
Endocrine Disruptors toxicity
High-Throughput Screening Assays
Hormones toxicity
Receptors, Thyroid Hormone agonists
Transcriptome drug effects
Zebrafish genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1873-1708
- Volume :
- 77
- Database :
- MEDLINE
- Journal :
- Reproductive toxicology (Elmsford, N.Y.)
- Publication Type :
- Academic Journal
- Accession number :
- 29458080
- Full Text :
- https://doi.org/10.1016/j.reprotox.2018.02.006